Survival Outcomes of Children with Relapsed or Refractory Myeloid Leukemia Associated with Down syndrome

Autor: Nikhil Raghuram, Kentaro Nakashima, Syaza Ab Rahman, Evangelia Antoniou, Torjus Skajaa, Pietro Merli, Anupam Verma, Karen R. Rabin, Catherine Aftandilian, Rishi Sury Kotecha, Daniel Ka Leung Cheuk, Kirsi Jahnukainen, Alexandra Kolenova, Walentyna Balwierz, Alice Norton, Maureen M O'Brien, Sonia Cellot, Ashley Chopek, Nira Arad-Cohen, Bianca F. Goemans, Marta Rojas-Vasquez, Hany Ariffin, Jack Bartram, Edward A Kolb, Franco Locatelli, Daisuke Hasegawa, Jan-Henning Klusmann, Henrik Hasle, Bryan McGuire, Lillian Sung, Johann K. Hitzler

Publikováno v: Raghuram, N, Nakashima, K, Ab Rahman, S, Antoniou, E, Skajaa, T, Merli, P, Verma, A, Rabin, K R, Aftandilian, C, Kotecha, R S, Cheuk, D K L, Jahnukainen, K, Kolenova, A, Balwierz, W, Norton, A, O'Brien, M M, Cellot, S, Chopek, A, Arad-Cohen, N, Goemans, B F, Rojas-Vasquez, M, Ariffin, H, Bartram, J, Kolb, E A, Locatelli, F, Hasegawa, D, Klusmann, J-H, Hasle, H, McGuire, B, Sung, L & Hitzler, J K 2023, ' Survival Outcomes of Children with Relapsed or Refractory Myeloid Leukemia Associated with Down syndrome ', Blood Advances . https://doi.org/10.1182/bloodadvances.2022009381

Children with Down syndrome (DS) are at a significantly higher risk of developing acute myeloid leukemia, also termed myeloid leukemia associated with DS (ML-DS). In contrast to the highly favorable prognosis of primary ML-DS, the limited data that a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31a0fcd1b97bcceef6f43bd5f4ef5a6f
https://doi.org/10.1182/bloodadvances.2022009381

Validation Study of the Heavy Menstrual Bleeding Questionnaire in Adolescents

Autor: Victoria Price, Robyn McLaughlin, Nancy Van Eyk, Koyo Usuba, Mark Belletrutti, Nancy L. Young, Meghan Pike, Ashley Chopek, Kristen A. Matteson, Amanda Bouchard

Publikováno v: Blood. 136:45-45

Introduction Heavy menstrual bleeding (HMB) is a common problem among adolescent girls that affects many aspects of their lives. Estimating the effect of HMB on health-related quality of life (HRQoL) is important but challenging, as there is no instr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f4a0d6b8f4780cc26c5bdc7b2cd48bee
https://doi.org/10.1182/blood-2020-134545

Researcher's Work from University of Malaya Medical Centre Focuses on Down Syndrome (Survival Outcomes of Children with Relapsed or Refractory Myeloid Leukemia Associated with Down syndrome).

Publikováno v: Hematology Week; 2/20/2023, p570-570, 1p